These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16026105)

  • 1. Managing type 2 diabetes mellitus in patients with obesity.
    Hauner H
    Treat Endocrinol; 2004; 3(4):223-32. PubMed ID: 16026105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity: a rational target for managing diabetes mellitus.
    Mooradian AD
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S79-83. PubMed ID: 11527093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and type 2 diabetes: a conflict of interests?
    Williams G
    Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S2-4. PubMed ID: 10455464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological intervention: the antiobesity approach.
    Rissanen A
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():27-30. PubMed ID: 9777325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
    Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
    Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.
    Gokcel A; Gumurdulu Y; Karakose H; Melek Ertorer E; Tanaci N; BascilTutuncu N; Guvener N
    Diabetes Obes Metab; 2002 Jan; 4(1):49-55. PubMed ID: 11874442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy of obesity.
    Finer N
    Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):717-42. PubMed ID: 12468417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Pediatric Obesity: An Umbrella Systematic Review.
    Rajjo T; Mohammed K; Alsawas M; Ahmed AT; Farah W; Asi N; Almasri J; Prokop LJ; Murad MH
    J Clin Endocrinol Metab; 2017 Mar; 102(3):763-775. PubMed ID: 28359101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.
    Miles JM; Leiter L; Hollander P; Wadden T; Anderson JW; Doyle M; Foreyt J; Aronne L; Klein S
    Diabetes Care; 2002 Jul; 25(7):1123-8. PubMed ID: 12087008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
    Sari R; Balci MK; Cakir M; Altunbas H; Karayalcin U
    Endocr Res; 2004 May; 30(2):159-67. PubMed ID: 15473126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term pharmacotherapy for obesity and overweight.
    Padwal R; Li SK; Lau DC
    Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.
    Bloch KV; Salles GF; Muxfeldt ES; Da Rocha Nogueira A
    J Hypertens; 2003 Nov; 21(11):2159-65. PubMed ID: 14597860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and effective management of the obese patient.
    Collazo-Clavell ML
    Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.